Radiotherapy is one of the main therapeutic methods for treating cancer. The digestive
system consists of the gastrointestinal tract and the accessory organs of digestion (the …

This comprehensive review addresses most organs at risk involved in planning optimization
for prostate cancer. It can be considered an update of a previous educational review that …

Abstract Background/Purpose This study describes late bowel morbidity prospectively
assessed in the multi-institutional EMBRACE study on MRI-guided adaptive brachytherapy …

Purpose The aims of this study were to systematically review tolerance doses for late distinct
gastrointestinal (GI), genitourinary (GU), and sexual dysfunction (SD) symptoms after …

Background Advanced pelvic radiotherapy techniques aim to reduce late bowel toxicity
which can severely impact the lives of pelvic cancer survivors. Although advanced …

Purpose The purpose was to evaluate patient-and treatment-related risk factors for physician-
assessed and patient-reported gastrointestinal (GI) symptoms after radio (chemo) therapy …

Purpose Changes in fraction size of external beam radiation therapy exert nonlinear effects
on subsequent toxicity. Commonly described by the linear-quadratic model, fraction size …

Abstract Background: Gastro-intestinal (GI) toxicity after radiotherapy (RT) for prostate
cancer reduces patient's quality of life. In this study, we explored associations between …

Background and purpose Radiotherapy (RT) induced genitourinary (GU) morbidity is
typically assessed by physicians as single symptoms or aggregated scores including …

Background and purpose Intestinal toxicity is commonly experienced during whole-pelvis
intensity-modulated radiotherapy (WPRT) for prostate cancer. The aim of the current study …